A retrospective study to evaluate the feasibility of performing a combined F18- fluciclovine and F18-NaF study and the biodistribution of the combined radiotracers in patients with prostate cancer
Latest Information Update: 22 Jun 2020
At a glance
- Drugs Fluciclovine 18F (Primary) ; Sodium fluoride (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
Most Recent Events
- 22 Jun 2020 New trial record
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology